Multi-target-Directed Ligands To Combat Neurodegenerative Diseases

Cited by (1,000)

Items 501–600 of 1,000

1. Design of more potent squalene synthase inhibitors with multiple activities
   Angeliki P. Kourounakis, Alexios N. Matralis, Anastasios Nikitakis · 2010 · Bioorganic & Medicinal Chemistry
2. Design, synthesis and in vitro testing of 7-methoxytacrine-amantadine analogues: a novel cholinesterase inhibitors for the treatment of Alzheimer’s disease
   Katarína Špilovská, Jan Korábečný, Anna Horova, Kamil Musílek, Eugenie Nepovimová, Lucie Drtinová, Zuzana Gažová, Katarína Šipošová, Rafael Doležal, Daniel Jun et al. · 2015 · Medicinal Chemistry Research
3. New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer’s Disease
   Rajeshwari Rajeshwari, Karam Chand, Emanuel Candeias, Sandra M. Cardoso, Sı́lvia Chaves, Maria Amélia Santos · 2019 · Molecules
4. Terpenes as Potential Anti-Alzheimer’s Disease Agents
   Elisabete Lima, Jorge Medeiros · 2024 · Applied Sciences
5. Design, synthesis and biological evaluation of novel indano- and thiaindano-pyrazoles with potential interest for Alzheimer's disease
   David Genest, Christophe Rochais, Cédric Lecoutey, Jana Sopková‐de Oliveira Santos, Céline Ballandonne, Sabrina Butt‐Gueulle, Rémi Legay, Marc Since, Patrick Dallemagne · 2013 · MedChemComm
6. Design, synthesis, and evaluation of 2-piperidone derivatives for the inhibition of β-amyloid aggregation and inflammation mediated neurotoxicity
   Lei Li, Ming Chen, Fengchao Jiang · 2016 · Bioorganic & Medicinal Chemistry
7. Screening and identification of Caulis Sinomenii bioactive ingredients with dual‐target NF‐ κ B inhibition and β 2‐ AR agonizing activities
   Dan Sun, Yanqi Han, Weiya Wang, Zengyong Wang, Xiaoyao Ma, Yuanyuan Hou, Gang Bai · 2016 · Biomedical Chromatography
8. Application of quinazoline and pyrido[3,2-d]pyrimidine templates to design multi-targeting agents in Alzheimer's disease
   Tarek Mohamed, Mandeep Kaur Mann, Praveen P. N. Rao · 2017 · RSC Advances
9. Salvia plebeia Extract Inhibits Xanthine Oxidase Activity In Vitro and Reduces Serum Uric Acid in an Animal Model of Hyperuricemia
   Jin Kim, Woo Kim, Jung Hyun, Jong Eun Lee, Jin Gwan Kwon, Changon Seo, Myung‐Jin Song, Chun Whan Choi, Seong‐Tshool Hong, Kyu Hee Park et al. · 2017 · Planta Medica
10. Exploring the chelating capacity of 2-hydroxyphenyl-benzimidazole based hybrids with multi-target ability as anti-Alzheimer's agents
    Sı́lvia Chaves, Asha Hiremathad, Daniel Tomás, Rangappa Sangappa Keri, Luca Piemontese, Maria Amélia Santos · 2018 · New Journal of Chemistry
11. Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC/AChE inhibitors for Alzheimer’s disease
    Pengxia Qin, Yingying Ran, Fei Xie, Yujing Liu, Chao Wei, Xiaoyi Luan, Jingde Wu · 2023 · Bioorganic & Medicinal Chemistry
12. Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals
    Hafsa Amat-ur-Rasool, Mehboob Ahmed · 2015 · PLoS ONE
13. 3-Hydroxypyridinone Derivatives as Metal-Sequestering Agents for Therapeutic Use
    Maria Amélia Santos, Sı́lvia Chaves · 2015 · Future Medicinal Chemistry
14. Concomitant manipulation of murine NMDA- and AMPA-receptors to produce pro-cognitive drug effects in mice
    Julie Vignisse, Harry W.M. Steinbusch, Vladimir V. Grigoriev, Alexei Bolkunov, Alexey N. Proshin, Lucien Bettendorff, Сергей Олегович Бачурин, Tatyana V. Strekalova · 2013 · European Neuropsychopharmacology
15. Exploration of a Library of 3,4‐(Methylenedioxy)aniline‐Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation
    Rati Kailash Prasad Tripathi, Gopal K. Rai, Senthil Raja Ayyannan · 2016 · ChemMedChem
16. Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer’s disease
    Gang Cheng, Ping Xu, Minkui Zhang, Jing Chen, Rong Sheng, Yongmin Ma · 2018 · Bioorganic & Medicinal Chemistry
17. Systematic Investigation of Dual-Target-Directed Ligands
    Vittorio Lembo, Giovanni Bottegoni · 2024 · Journal of Medicinal Chemistry
18. Multi-target directed ligands inspired natural products as an effective approach for the treatment of complex chronic health disorders
    Amira E Shaaban, Ahmed R. Ali, Seif-Eldin Nasr Ayyad, Farid Abd Al-raheem Badria · 2024 · Bioorganic Chemistry
19. 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases
    Pierre Koch, Rhalid Akkari, Andreas Brunschweiger, Thomas Borrmann, Miriam Schlenk, Petra Küppers, Meryem Köse, Hamid Radjainia, Jörg Hockemeyer, Anna Drabczyńska et al. · 2013 · Bioorganic & Medicinal Chemistry
20. Nature‐Inspired Multifunctional Ligands: Focusing on Amyloid‐Based Molecular Mechanisms of Alzheimer's Disease
    Elena Simoni, Melania Maria Serafini, Manuela Bartolini, Roberta Caporaso, Antonella Pinto, Daniela Necchi, Jessica Fiori, Vincenza Andrisano, Anna Minarini, Cristina Lanni et al. · 2015 · ChemMedChem
21. Designing prodrugs for the treatment of Parkinson's disease
    Piera Sozio, Laura Serafina Cerasa, Anna Abbadessa, Antonio Di Stefano · 2012 · Expert Opinion on Drug Discovery
22. Chemoinformatic Database Building and in Silico Hit-Identification of Potential Multi-Targeting Bioactive Compounds Extracted from Mushroom Species
    Annalisa Maruca, Federica Moraca, Roberta Rocca, Fulvia Molisani, Francesca Danila Alcaro, Maria Concetta Gidaro, Stefano Alcaro, Giosuè Costa, Francesco Ortuso · 2017 · Molecules
23. Design, synthesis, in vitro and in vivo evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against Alzheimer’s disease
    Jun Mo, Tingkai Chen, Hongyu Yang, Yan Guo, Qi Li, Yuting Qiao, Hongzhi Lin, Feng Feng, Wenyuan Liu, Yao Chen et al. · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
24. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer’s disease
    Sai‐Sai Xie, Jing Liu, Chunli Tang, Chengyun Pang, Qing Li, Yuelian Qin, Xiaojie Nong, Zhipeng Zhang, Jie Fang Guo, Maojun Cheng et al. · 2020 · European Journal of Medicinal Chemistry
25. Indoloquinoxaline derivatives as promising multi-functional anti-Alzheimer agents
    Ashish M. Kanhed, Dushyant V. Patel, Nirav R. Patel, Anshuman Sinha, Priyanka S. Thakor, Kishan B. Patel, Navnit K. Prajapati, Kirti V. Patel, Mange Ram Yadav · 2020 · Journal of Biomolecular Structure and Dynamics
26. The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actions
    Karthikkumar Venkatachalam, Nermin Eissa, Mohamed Al Awad, Petrilla Jayaprakash, Sicheng Zhong, Frauke Stölting, Holger Stark, Bassem Shaban Sadek · 2021 · Biomedicine & Pharmacotherapy
27. Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer’s Diseases: Emerging Paradigms and Strategies
    Narayanaperumal Pravin, Krzysztof Jóźwiak · 2022 · International Journal of Molecular Sciences
28. Reaction site-driven regioselective synthesis of AChE inhibitors
    Emilia Oueis, Gianluca Santoni, Cyril Ronco, Olga A. Syzgantseva, Vincent Tognetti, Laurent Joubert, Anthony Romieu, Martin Weik, Ludovic Jean, Cyrille Sabot et al. · 2013 · Organic & Biomolecular Chemistry
29. Evaluation of multifunctional synthetic tetralone derivatives for treatment of Alzheimer's disease
    Jing Leng, Hua‐Li Qin, Kaicheng Zhu, Ibrahim Jantan, Muhammad Ajaz Hussain, Muhammad Sher, Muhammad Wahab Amjad, Muhammad Naeem ul Hassan, Waqas Ahmad, Syed Nasir Abbas Bukhari · 2016 · Chemical Biology & Drug Design
30. Synthesis, antioxidant and cytoprotective evaluation of potential antiatherogenic phenolic hydrazones. A structure–activity relationship insight
    Corinne Vanucci‐Bacqué, Chantal Carayon, Corinne Bernis, Caroline Camaré, Anne Nègre‐Salvayre, Florence Bedos‐Belval, Michel Baltas · 2014 · Bioorganic & Medicinal Chemistry
31. Focused design of polypharmacophoric neuroprotective compounds: Conjugates of γ-carbolines with carbazole derivatives and tetrahydrocarbazole
    Галина Ф. Махаева, Vladimir B. Sokolov, E. F. Shevtsova, Надежда Владимировна Ковалева, Sofya V. Lushchekina, Natalia P. Boltneva, Елена Владимировна Рудакова, Aleksey Yu. Aksinenko, Pavel N. Shevtsov, Неганова Маргарита Евгеньевна et al. · 2017 · Pure and Applied Chemistry
32. Multi-targeted drug design strategies for the treatment of schizophrenia
    Piotr Stępnicki, Magda Kondej, Oliwia Koszła, Justyna Żuk, Agnieszka Anna Kaczor · 2020 · Expert Opinion on Drug Discovery
33. Novel arylcarbamate-N-acylhydrazones derivatives as promising BuChE inhibitors: Design, synthesis, molecular modeling and biological evaluation
    Diego Alberto dos Santos Yamazaki, Andrew Matheus Frederico Rozada, Paula Baréa, Elaine Chamorro Reis, Ernani A. Basso, Maria Helena Sarragiotto, Flávio Augusto Vicente Seixas, Gisele F. Gauze · 2021 · Bioorganic & Medicinal Chemistry
34. Synthesis of Monomeric Derivatives To Probe Memoquin’s Bivalent Interactions
    María Laura Bolognesi, Gianpaolo Chiriano, Manuela Bartolini, Francesca Mancini, Giovanni Bottegoni, Valentina Maestri, Stefan Czvitkovich, Manfred Windisch, Andrea Cavalli, Anna Minarini et al. · 2011 · Journal of Medicinal Chemistry
35. Dual‐Acting Diether Derivatives of Piperidine and Homopiperidine with Histamine H3 Receptor Antagonistic and Anticholinesterase Activity
    Marek Bajda, Kamil Kuder, Dorota Łażewska, Katarzyna Kieć‐Kononowicz, Anna Więckowska, Michalina Ignasik, Natalia Szałaj, Jakub Jończyk, Barbara Malawska · 2012 · Archiv der Pharmazie
36. Site-Activated Chelators Derived from Anti-Parkinson Drug Rasagiline as a Potential Safer and More Effective Approach to the Treatment of Alzheimer’s Disease
    Hailin Zheng, Mati Fridkin, Moussa B. H. Youdim · 2010 · Neurochemical Research
37. D-512 and D-440 as Novel Multifunctional Dopamine Agonists: Characterization of Neuroprotection Properties and Evaluation of In Vivo Efficacy in a Parkinson’s Disease Animal Model
    Soumava Santra, Liping Xu, Mrudang M. Shah, Mark Johnson, Aloke K. Dutta · 2013 · ACS Chemical Neuroscience
38. New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds
    Martin Nimczick, Michael W. Decker · 2015 · ChemMedChem
39. Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
    Ramón Cacabelos, Olaia A. Martínez-Iglesias, Natalia Cacabelos, Iván Carrera, Lola Corzo, Vinogran Naidoo · 2024 · Life
40. Ellagic Acid: A Green Multi-Target Weapon That Reduces Oxidative Stress and Inflammation to Prevent and Improve the Condition of Alzheimer’s Disease
    Silvana Alfei, Guendalina Zuccari · 2025 · International Journal of Molecular Sciences
41. Small Multitarget Molecules Incorporating the Enone Moiety
    Thalia Liargkova, Nikolaos Eleftheriadis, Frank J. Dekker, Efstathia Voulgari, Konstantinos Avgoustakis, Marina Sagnou, Barbara Mavroidi, Maria Pelecanou, Dimitra Hadjipavlou‐Litina · 2019 · Molecules
42. Immune system activation by natural products and complex fractions: a network pharmacology approach in cancer treatment
    Alejandra Gomez‐Cadena, Alfonso Barreto, Susana Fioretino, Camilla Jandus · 2020 · Cell Stress
43. Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol‐3‐kinase (PI3K): Current and Future Prospects
    Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Carlos Alberto Manssour Fraga · 2020 · ChemMedChem
44. Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer’s Disease
    Annachiara Gandini, Ana Elisa Gonçalves, Silvia Strocchi, Claudia Albertini, Jana Janočková, Anna Tramarin, Daniela Grifoni, Eleonora Poeta, Ondřej Soukup, Diego Muñoz‐Torrero et al. · 2022 · ACS Chemical Neuroscience
45. Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease
    Aliki Drakontaeidi, Eleni A. Pontiki · 2024 · International Journal of Molecular Sciences
46. Fluorinated benzophenone derivatives: Balanced multipotent agents for Alzheimer's disease
    Federica Belluti, Angela De Simone, Andrea Tarozzi, Manuela Bartolini, Alice Djemil, Alessandra Bisi, Silvia Gobbi, Serena Montanari, Andrea Cavalli, Vincenza Andrisano et al. · 2014 · European Journal of Medicinal Chemistry
47. Merging the Structural Motifs of Functionalized Amino Acids and α-Aminoamides: Compounds with Significant Anticonvulsant Activities
    Christophe Salomé, Elise Salomé-Grosjean, James P. Stables, Harold Kohn · 2010 · Journal of Medicinal Chemistry
48. Neuroprotective Role of Dopamine Agonists
    María Trinidad Herrero, Javier Pagonabarraga, Gurutz Linazasoro · 2011 · The Neurologist
49. Cholinesterase inhibitory activity of chlorophenoxy derivatives—Histamine H3 receptor ligands
    Dorota Łażewska, Jakub Jończyk, Marek Bajda, Natalia Szałaj, Anna Więckowska, Dawid Panek, Caitlin Moore, Kamil Kuder, Barbara Malawska, Katarzyna Kieć‐Kononowicz · 2016 · Bioorganic & Medicinal Chemistry Letters
50. Vibrational spectroscopic, molecular docking and quantum chemical studies on 6-aminonicotinamide
    R. Mohamed Asath, Selvarajan Premkumar, T. Mathavan, A. Milton Franklin Benial · 2016 · Journal of Molecular Structure
51. Towards a Novel Class of Multitarget-Directed Ligands: Dual P2X7–NMDA Receptor Antagonists
    Olga Karoutzou, Seung‐Hwa Kwak, So‐Deok Lee, Daina Martínez‐Falguera, Francesc Xavier Sureda, Santiago Vázquez, Yong‐Chul Kim, Marta Barniol‐Xicota · 2018 · Molecules
52. Pharmacological investigation of quinoxaline-bisthiazoles as multitarget-directed ligands for the treatment of Alzheimer’s disease
    Sneha R. Sagar, Devendra Pratap Singh, Rajesh D. Das, Nirupa B. Panchal, Vasudevan Sudarsanam, Manish Nivsarkar, Kamala K. Vasu · 2019 · Bioorganic Chemistry
53. Herbs to curb cyclic nucleotide phosphodiesterase and their potential role in Alzheimer’s disease
    Ashwani Kumar, Vishavdeep Sharma, Vijay Pal Singh, Madhu Kaundal, Manish Gupta, Jitender B. Bariwal, Rahul R Deshmukh · 2015 · Mechanisms of Ageing and Development
54. Novel pyrrole based triazole moiety as therapeutic hybrid: synthesis, characterization and anti-Alzheimer potential with molecular mechanism of protein ligand profile
    Shoaib Ahmed Khan, Tayyiaba Iqbal, Muhammad Bilal Khan, Rafaqat Hussain, Yousaf Khan, Hany W. Darwish · 2024 · BMC Chemistry
55. Chemical and Pharmacological Studies on Enantiomerically Pure p‐Methoxytacripyrines, Promising Multi‐Target‐Directed Ligands for the Treatment of Alzheimer’s Disease
    Manuela Bartolini, Marco Pistolozzi, Vincenza Andrisano, Javier Egea, Manuela G. López, Isabel Iriepa, Ignacio Moraleda, E. Galvez‐Ruano, Jose Luis Marco, Abdelouahid Samadi · 2011 · ChemMedChem
56. Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1−42 Aggregation Inhibitors for Alzheimer's Disease Therapy
    Youssef Dgachi, Lhassane Ismaïli, Damijan Knez, Mohamed Benchekroun, Hélène Martin, Natalia Szałaj, Sarah Wehle, Óscar M. Bautista‐Aguilera, Vincent Luzet, Alexandre Bonnet et al. · 2016 · ChemMedChem
57. DADS Analogues Ameliorated the Cognitive Impairments of Alzheimer-Like Rat Model Induced by Scopolamine
    Apra Manral, Poonam Meena, Vikas Saini, Fouzia Siraj, Shruti Shalini, Manisha Tiwari · 2016 · Neurotoxicity Research
58. Design, synthesis and biological evaluation of quinazoline–phosphoramidate mustard conjugates as anticancer drugs
    Songwen Lin, Yingbo Li, Yufen Zheng, Laichun Luo, Qi Sun, Zemei Ge, Tieming Cheng, Runtao Li · 2017 · European Journal of Medicinal Chemistry
59. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer’s disease
    Akhil Kumar, Gaurava Srivastava, Swati Srivastava, Seema Verma, Arvind Negi, Ashok Kumar Sharma · 2017 · Journal of Molecular Modeling
60. Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer’s disease
    Huali Yang, Pei Cai, Qiaohong Liu, Xuelian Yang, Siqiang Fang, Yan-Wei Tang, Cheng Wang, Xiaobing Wang, Ling‐Yi Kong · 2017 · Bioorganic & Medicinal Chemistry
61. Selected 1,3‐Benzodioxine‐Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors
    Geum Seok Jeong, Swafvan Kaipakasseri, Sang Ryong Lee, Najat Marraiki, Gaber El‐Saber Batiha, Sanal Dev, Ashique Palakkathondi, Fathima Sahla Kavully, Nicola Gambacorta, Orazio Nicolotti et al. · 2020 · ChemMedChem
62. Structure‐Guided Design of G‐Protein‐Coupled Receptor Polypharmacology
    Stefanie Kampen, Duc Duy Vo, Xiaoqun Zhang, Nicolas Panel, Yunting Yang, Mariama Jaiteh, Pierre G. Matricon, Per Svenningsson, Jose Manuel Brea, Marı́a Isabel Loza et al. · 2021 · Angewandte Chemie International Edition
63. Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents
    Elisabete Lima, Jorge Medeiros · 2022 · Marine Drugs
64. Design, synthesis and antitumor activity study of PARP-1/HDAC dual targeting inhibitors
    Ziwei Chi, Ying Bai, Jing Li, Kewei Wang, Yungen Xu, Yepeng Luan · 2022 · Bioorganic & Medicinal Chemistry Letters
65. sym-Triazines for Directed Multitarget Modulation of Cholinesterases and Amyloid-β in Alzheimer’s Disease
    Anthony J. Veloso, Devjani Dhar, Ari M. Chow, Biao Zhang, Derek W.F. Tang, Hashwin V. S. Ganesh, Svetlana N. Mikhaylichenko, Ian R. Brown, Kağan Kerman · 2012 · ACS Chemical Neuroscience
66. New Treatment for Alzheimer’s Disease, Kamikihito, Reverses Amyloid‐β‐Induced Progression of Tau Phosphorylation and Axonal Atrophy
    Hidetoshi Watari, Yutaka Shimada, Chihiro Tohda · 2014 · Evidence-based Complementary and Alternative Medicine
67. Synthetic polyamines: an overview of their multiple biological activities
    Anna Minarini, Andrea Milelli, Vincenzo Tumiatti, Michela Rosini, María Laura Bolognesi, Carlo Melchiorre · 2009 · Amino Acids
68. DNA-spheres decorated with magnetic nanocomposites based on terminal transfer reactions for versatile target detection and cellular targeted drug delivery
    Yingshu Guo, Yujie Wang, Shuang Li, Li Niu, Di Wei, Shusheng Zhang · 2017 · Chemical Communications
69. Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer’s disease
    Zhipei Sang, Keren Wang, Huifang Wang, Huijuan Wang, Qianwen Ma, Xue Han, Mengyao Ye, Lintao Yu, Wenmin Liu · 2017 · Bioorganic & Medicinal Chemistry Letters
70. Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease
    Jinhui Hu, Baijiao An, Tingting Pan, Zhengcunxiao Li, Ling Huang, Xingshu Li · 2018 · Bioorganic & Medicinal Chemistry
71. Computational approach to suggest a new multi-target-directed ligand as a potential medication for Alzheimer’s disease
    Mahboobeh Eslami, Navid Nezafat, Manica Negahdaripour, Younes Ghasemi · 2019 · Journal of Biomolecular Structure and Dynamics
72. Multifunctional indanone–chalcone hybrid compounds with anti-β-amyloid (Aβ) aggregation, monoamine oxidase B (MAO-B) inhibition and neuroprotective properties against Alzheimer’s disease
    Keren Wang, Lintao Yu, Jian Shi, Wenmin Liu, Zhipei Sang · 2019 · Medicinal Chemistry Research
73. Identification of Indazole-Based Thiadiazole-Bearing Thiazolidinone Hybrid Derivatives: Theoretical and Computational Approaches to Develop Promising Anti-Alzheimer’s Candidates
    Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Wajid Ur Rehman, Aneela Maalik, Urooba Gulshan, Mohamed W. Attwa, Hany W. Darwish, Hazem A. Ghabbour, Nawab Ali · 2023 · Pharmaceuticals
74. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies
    Yuqing Wei, Sheng Zhong, Huajing Yang, Xueqing Wang, Bingbing Lv, Yaoyao Bian, Yuqiong Pei, Chunlei Xu, Qun Zhao, Wu Yulan et al. · 2024 · European Journal of Medicinal Chemistry
75. Applying a multitarget rational drug design strategy: the first set of modulators with potent and balanced activity toward dopamine D3 receptor and fatty acid amide hydrolase
    Alessio De Simone, G.F. Ruda, Clara Albani, Glauco Tarozzo, Tiziano Bandiera, Daniele Piomelli, Andrea Cavalli, Giovanni Bottegoni · 2014 · Chemical Communications
76. Synthesis, biological activity, and biopharmaceutical characterization of tacrine dimers as acetylcholinesterase inhibitors
    Shuai Qian, Lisi He, Shinghung Mak, Yifan Han, Chun‐Yu Ho, Zhong Zuo · 2014 · International Journal of Pharmaceutics
77. Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments
    Giovanni Bottegoni, Marina Veronesi, Paola Bisignano, Puneet Kacker, Angelo Danilo Favia, Andrea Cavalli · 2015 · ChemMedChem
78. Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[d][1,2]selenazol-3(2H)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant
    Bo Wang, Zhiren Wang, Hong Chen, Chuan‐Jun Lu, Xingshu Li · 2016 · Bioorganic & Medicinal Chemistry
79. Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and β-Secretase for treatment of Alzheimer's disease
    Sushant Kumar Shrivastava, Avhad Ashok Nivrutti, Bhagwati Bhardwaj, Digambar Kumar Waiker, Akash Verma, Prabhash Nath Tripathi, Manish Kumar Tripathi, Poorvi Saraf · 2022 · Journal of Molecular Structure
80. Development of Isoxazoline‐Containing Peptidomimetics as Dual αvβ3 and α5β1 Integrin Ligands
    Alessandra Tolomelli, Luca Gentilucci, Elisa Mosconi, Angelo Viola, Samantha Deianira Dattoli, Monica Baiula, Santi Mario Spampinato, Laura Belvisi, Monica Civera · 2011 · ChemMedChem
81. Structure–activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action
    María Laura Bolognesi, Manuela Bartolini, Michela Rosini, Vincenza Andrisano, Carlo Melchiorre · 2009 · Bioorganic & Medicinal Chemistry Letters
82. Novel multipotent phenylthiazole–tacrine hybrids for the inhibition of cholinesterase activity, β-amyloid aggregation and Ca2+ overload
    Yue Wang, Fang Wang, Junping Yu, Fengchao Jiang, Xin‐Lei Guan, Can-Ming Wang, Lei Li, Hui Cao, Mingxing Li, Jianguo Chen · 2012 · Bioorganic & Medicinal Chemistry
83. Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of humanacetylcholinesterase and butyrylcholinesterase
    Yue‐Hu Wang, Qin-Li Wan, Cheng-Ding Gu, Huai‐Rong Luo, Chunlin Long · 2012 · Chemistry Central Journal
84. Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer’s Disease-Diabetes Dual Therapy
    Syed Mohd Danish Rizvi, Sibhghatulla Shaikh, Deeba Naaz, Shazi Shakil, Adnan Ahmad, Mohd Haneef, Adel Mohammed Abuzenadah · 2016 · Neurochemical Research
85. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies
    Michał Załuski, Jakub Schabikowski, Miriam Schlenk, Agnieszka Olejarz‐Maciej, Bartłomiej Kubas, Tadeusz P. Karcz, Kamil Kuder, Gniewomir Latacz, Małgorzata Zygmunt, David Synak et al. · 2019 · Bioorganic & Medicinal Chemistry
86. Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase
    Idalet Engelbrecht, Jacobus Petrus Petzer, Anél Petzer · 2019 · Central Nervous System Agents in Medicinal Chemistry
87. First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease
    Benjamin Guieu, Cédric Lecoutey, Rémi Legay, Audrey Davis, Jana Sopková‐de Oliveira Santos, Cosimo Altomare, Marco Catto, Christophe Rochais, Patrick Dallemagne · 2020 · Molecules
88. Hydroxy-substituted trans -cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease
    Angela De Simone, Manuela Bartolini, Andrea Baschieri, Kim Yang-Ping Apperley, Huan Huan Chen, Melissa Guardigni, Serena Montanari, Tereza Kobrlová, Ondřej Soukup, Luca Valgimigli et al. · 2017 · European Journal of Medicinal Chemistry
89. Mitochondria-targeted nanovesicles for ursodeoxycholic acid delivery to combat neurodegeneration by ameliorating mitochondrial dysfunction
    Shizheng Zhang, Mengmeng Li, Yuan Li, Shike Yang, Jian Wang, Xiaoxiang Ren, Xiu-Hui Wang, Long Bai, Jianping Huang, Zhen Geng et al. · 2025 · Journal of Nanobiotechnology
90. Bis(9)-(−)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice
    Ting Liu, Zheng Xia, Weiwei Zhang, Jianrong Xu, Xin-xing Ge, Juan Li, Yong‐Yao Cui, Zhuibai Qiu, Jun Xu, Qiong Xie et al. · 2012 · Pharmacology Biochemistry and Behavior
91. Chemical probes for biological systems
    Ricard García-Serna, Jordi Mestres · 2010 · Drug Discovery Today
92. Multifunctional D2/D3 Agonist D-520 with High in Vivo Efficacy: Modulator of Toxicity of Alpha-Synuclein Aggregates
    Gyan Prakash Modi, Chandrashekhar Voshavar, Sanjib Gogoi, Mrudang M. Shah, Tamara Antonio, Maarten E. A. Reith, Aloke K. Dutta · 2014 · ACS Chemical Neuroscience
93. Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer’s Disease
    Elisa Uliassi, Andressa Souza de Oliveira, Luciana de Camargo Nascente, Luiz Antônio Soares Romeiro, María Laura Bolognesi · 2021 · Molecules
94. Adenosine A2A receptor antagonists as novel anti-Parkinsonian agents: a review of structure-activity relationships
    Faizul Azam, I A Ibn-Rajab, A A Alruiad · 2009 · Die Pharmazie
95. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer’s disease
    Rui Xu, Ganyuan Xiao, Yan Li, Hongyan Liu, Qing Song, Xiaoyu Zhang, Ziyi Yang, Yunxiaozhu Zheng, Zhenghuai Tan, Yong Deng · 2018 · Bioorganic & Medicinal Chemistry
96. Resveratrol targeting tau proteins, amyloid‐beta aggregations, and their adverse effects: An updated review
    Milad Ashrafizadeh, Ali Zarrabi, Masoud Najafi, Saeed Samarghandian, Reza Mohammadinejad, Kwang Seok Ahn · 2020 · Phytotherapy Research
97. Ag@ S -nitrosothiol core–shell nanoparticles for chemo and photothermal synergistic tumor targeted therapy
    Tuanwei Liu, Xiao Li, Jilan Wang, Ping Zhang, Xiao‐Ying Huang, Zhide Zhang, Dian‐Shun Guo, Xinlin Yang · 2020 · Journal of Materials Chemistry B
98. Donepezil-Inspired Multitargeting Indanone Derivatives as Effective Anti-Alzheimer’s Agents
    Jatinder Vir Singh, Shubham Thakur, Nitish Kumar, Harjeet Singh, Venus Singh Mithu, Harpreet Singh, Kavita Bhagat, Harmandeep Kaur Gulati, Anchal Sharma, Harbinder Singh et al. · 2022 · ACS Chemical Neuroscience
99. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease
    Elisa Uliassi, Christian Bergamini, Nicola Rizzardi, Marina Naldi, Ángel Cores, Manuela Bartolini, José Carlos Menéndez, María Laura Bolognesi · 2023 · Bioorganic & Medicinal Chemistry
100. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models
     Julie Kelly, Noreen T. Boyle, Natalie Cole, Gillian R. Slator, Maria Alessandra Colivicchi, Chiara Stefanini, Oliviero L. Gobbo, Gaia Scalabrino, Sinéad M. Ryan, Marwa Elamin et al. · 2014 · Neuropharmacology